Marita Westhrin
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial.
Journal: Med (New York, N.Y.)
Published: October 30, 2024
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement.
Journal: Molecular therapy. Oncology
Published: October 02, 2024
Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2023
The effects of surface treatments on electron beam melted Ti-6Al-4V disks on osteogenesis of human mesenchymal stromal cells.
Journal: Biomaterials advances
Published: August 11, 2022
Revealing the influence of electron beam melted Ti-6Al-4V scaffolds on osteogenesis of human bone marrow-derived mesenchymal stromal cells.
Journal: Journal of materials science. Materials in medicine
Published: April 19, 2021
Smac-mimetics reduce numbers and viability of human osteoclasts.
Journal: Cell death discovery
Published: December 10, 2020
Monoclonal immunoglobulins promote bone loss in multiple myeloma.
Journal: Blood
Published: March 30, 2020
Serum protein N-glycosylation changes in multiple myeloma.
Journal: Biochimica et biophysica acta. General subjects
Published: August 24, 2018
Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes.
Journal: Biomarker research
Published: March 09, 2018
Last Updated: 09/26/2026